Bacteria can evolve resistance to life-saving drugs they've never seen. Here's how.

In the 1940s, the famous Luria–Delbrück experiment showed that bacteria evolve resistance to drugs they'd never encountered thanks to a random mutational process.

A microscopic image of purple and blue rod-shaped bacteria.
Bacteria are evolutionarily primed to outpace drug developers.
(Image credit: National Institute of Allergy and Infectious Diseases, National Institutes of Health/Flickr, CC BY-NC)

Do bacteria mutate randomly, or do they mutate for a purpose? Researchers have been puzzling over this conundrum for over a century.

In 1943, microbiologist Salvador Luria and physicist turned biologist Max Delbrück invented an experiment to argue that bacteria mutated aimlessly. Using their test, other scientists showed that bacteria could acquire resistance to antibiotics they hadn't encountered before.

Qi Zheng
Professor of Biostatistics, Texas A&M University

I began researching into the Luria–Delbrück distribution in 1998 at the suggestion of a renowned statistical distribution expert. The Luria–Delbrück distribution is a family of related distributions describing the probabilistic behavior of the numbers of mutants observed in a Luria–Delbrück experiment, which is also called the fluctuation experiment. The Luria–Delbrück distribution plays a key role in allowing microbiologists to extract information on microbial mutation rates from mutant count data generated by fluctuation experiments. I have devised an array of computational methods for the analysis of data generated by fluctuation experiments. I also made a computer package and a Web tool to help biologists analyze data from fluctuation experiments. My research results have appeared in mathematics, statistics and biology journals. My second research interest is in statistical education for public health students.